Search Results - "Kanigsberg, Nordau D."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept by Gavigan, Geneviève M., Kanigsberg, Nordau D., Ramien, Michele L.

    Published in Journal of cutaneous medicine and surgery (01-09-2018)
    “…We report a case of an 11-year-old female with Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) overlap, most likely triggered by…”
    Get full text
    Journal Article
  2. 2

    Primary Cutaneous Histoplasma capsulatum Infection in a Patient Treated With Fingolimod: A Case Report by Veillet-Lemay, Gabrielle M., Sawchuk, Michael A., Kanigsberg, Nordau D.

    Published in Journal of cutaneous medicine and surgery (01-11-2017)
    “…Fingolimod is an immune-modulating drug used in the treatment of multiple sclerosis. Histoplasma capsulatum is a dimorphic fungus that can infect humans…”
    Get full text
    Journal Article
  3. 3

    Localized pruritus: A presenting symptom of a spinal cord tumor in a child with features of neurofibromatosis by Johnson, Robert E., Kanigsberg, Nordau D., Jimenez, Carmencita L.

    “…Central nervous system (CNS) and spinal cord tumors are not uncommon in patients with neurofibromatosis (NF); however, it is impossible to select patients with…”
    Get full text
    Journal Article
  4. 4

    Localized pruritus: A presenting symptom of a spinal cord tumor in a child with features of neurofibromatosis by Johnson, Robert E., Kanigsberg, Nordau D., Jimenez, Carmencita L.

    “…Central nervous system (CNS) and spinal cord tumors are not uncommon in patients with neurofibromatosis (NF); however, it is impossible to select patients with…”
    Get full text
    Journal Article
  5. 5

    The effect of low dose methotrexate on bone density by CRANNEY, Ann B, MCKENDRY, Robert J, WELLS, George A, OOI, Daylily S, KANIGSBERG, Nordau D, KRAAG, Gunnar R, SMITH, C. Douglas

    Published in Journal of rheumatology (01-11-2001)
    “…OBJECTIVE: High dose methotrexate (MTX) has been linked with bone loss in oncology patients. However, it is unclear whether longterm low dose MTX used in the…”
    Get full text
    Journal Article
  6. 6
  7. 7